Parallel Advisors’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.14K Buy
972
+134
+16% +$1.2K ﹤0.01% 2792
2025
Q4
$6.79K Sell
838
-379
-31% -$4.14K ﹤0.01% 2750
2025
Q3
$17.3K Buy
1,217
+667
+121% +$8.81K ﹤0.01% 2321
2025
Q2
$7.18K Sell
550
-50
-8% -$687 ﹤0.01% 2610
2025
Q1
$8.93K Sell
600
-233
-28% -$4K ﹤0.01% 2478
2024
Q4
$15.1K Buy
833
+317
+61% +$4.27K ﹤0.01% 2257
2024
Q3
$6.93K Buy
516
+147
+40% +$2.17K ﹤0.01% 2518
2024
Q2
$5.11K Buy
+369
New +$5.84K ﹤0.01% 2540
2024
Q1
Sell
-102
Closed -$2.31K 3314
2023
Q4
$2.31K Buy
+102
New +$2.21K ﹤0.01% 2759
2023
Q2
Sell
-6
Closed -$134 3387
2023
Q1
$134 Hold
6
﹤0.01% 3312
2022
Q4
$159 Sell
6
-5
-45% -$163 ﹤0.01% 3219
2022
Q3
$0 Sell
11
-22
-67% -$566 ﹤0.01% 3171
2022
Q2
$1K Buy
33
+2
+6% +$37 ﹤0.01% 2717
2022
Q1
$1K Hold
31
﹤0.01% 2706
2021
Q4
$1K Hold
31
﹤0.01% 2839
2021
Q3
$1K Buy
+31
New +$582 ﹤0.01% 2818

Other funds holding CCRN

Parallel Advisors's CCRN Position: Q1 2026 in Review

Parallel Advisors increased its Cross Country Healthcare (CCRN) stake by 16% in Q1 2026, buying an estimated $1.2K and bringing the position to 972 shares worth $9.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2792.

Parallel Advisors first reported a position in CCRN in Q3 2021 and has held it in 16 quarters since. The position peaked at $17.3K in Q3 2025. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Parallel Advisors held 972 shares of Cross Country Healthcare worth $9.14K as of Q1 2026.
  • Parallel Advisors bought 134 Cross Country Healthcare shares in Q1 2026, an estimated $1.2K.
  • Cross Country Healthcare made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2792 holding.
  • Parallel Advisors first reported a position in Cross Country Healthcare in Q3 2021 and has held it in 16 quarters since.
  • Parallel Advisors's Cross Country Healthcare position peaked at $17.3K in Q3 2025.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.